Centene Co. (NYSE:CNC) Shares Acquired by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. boosted its position in Centene Co. (NYSE:CNC) by 0.6% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 1,558,706 shares of the company’s stock after acquiring an additional 9,206 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.31% of Centene worth $117,339,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CNC. GSA Capital Partners LLP grew its position in shares of Centene by 95.2% in the third quarter. GSA Capital Partners LLP now owns 12,391 shares of the company’s stock valued at $933,000 after purchasing an additional 6,043 shares during the period. Vantage Investment Partners LLC grew its holdings in Centene by 17.1% in the 3rd quarter. Vantage Investment Partners LLC now owns 683,817 shares of the company’s stock valued at $51,478,000 after buying an additional 99,904 shares during the period. Venturi Wealth Management LLC lifted its holdings in shares of Centene by 77.3% during the 3rd quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after acquiring an additional 507 shares during the period. Ashton Thomas Securities LLC boosted its position in shares of Centene by 8.4% in the third quarter. Ashton Thomas Securities LLC now owns 42,665 shares of the company’s stock worth $3,212,000 after acquiring an additional 3,298 shares during the last quarter. Finally, Los Angeles Capital Management LLC increased its position in Centene by 97.9% during the third quarter. Los Angeles Capital Management LLC now owns 14,130 shares of the company’s stock worth $1,064,000 after purchasing an additional 6,989 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Wells Fargo & Company decreased their price target on shares of Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Jefferies Financial Group downgraded Centene from a “buy” rating to a “hold” rating and cut their price objective for the stock from $83.00 to $69.00 in a report on Wednesday, July 24th. StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 28th. Stephens reaffirmed an “equal weight” rating and set a $78.00 price target on shares of Centene in a research report on Monday, August 5th. Finally, Robert W. Baird cut their target price on shares of Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $83.92.

Insider Buying and Selling

In related news, CFO Andrew Lynn Asher bought 17,200 shares of the company’s stock in a transaction dated Wednesday, November 13th. The stock was bought at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the transaction, the chief financial officer now owns 486,847 shares of the company’s stock, valued at approximately $28,305,284.58. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CEO Sarah London purchased 4,117 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now owns 667,229 shares in the company, valued at approximately $40,567,523.20. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Andrew Lynn Asher bought 17,200 shares of the company’s stock in a transaction on Wednesday, November 13th. The shares were acquired at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now directly owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.33% of the company’s stock.

Centene Trading Down 1.0 %

Shares of CNC opened at $58.04 on Thursday. The company has a market capitalization of $29.30 billion, a P/E ratio of 10.08, a P/E/G ratio of 0.80 and a beta of 0.49. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The stock has a 50-day moving average price of $68.91 and a 200 day moving average price of $71.30. Centene Co. has a one year low of $57.56 and a one year high of $81.42.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.